Hierarchical Fabrication of Plasmonic Superlattice Membrane by Aspect-Ratio Controllable Nanobricks for Label-Free Protein Detection

利用纵横比可控纳米块分级制备等离子体超晶格膜用于无标记蛋白质检测

阅读:2
作者:Yi Chen, Huang Liu, Haojing Yin, Qi Zhu, Gang Yao, Ning Gu

Abstract

Plasmonic superlattice membrane exhibits remarkable functional properties that are emerging from engineered assemblies of well-defined "meta-atoms," which is featured as a conceptual new category of two-dimensional optical metamaterials. The ability to build plasmonic membranes over macroscopic surfaces but with nanoscale ordering is crucial for systematically controlling the light-matter interactions and represents considerable advances for the bottom-up fabrication of soft optoelectronic devices and circuits. Through rational design, novel nanocrystals, and by engineering the packing orders, the hybridized plasmon signature can be customized, promoting controllable near-field confinement for surface-enhanced Raman scattering (SERS) based detection. However, building such 2D architectures has proven to be remarkably challenging due to the complicated interparticle forces and multiscale interactions during self-assembly. Here, we report on the fabrication of ultralong-nanobrick-based giant plasmonic superlattice membranes as high-performance SERS substrates for ultrasensitive and label-free protein detection. Using aspect-ratio controllable short-to-ultralong nanobricks as building blocks, we construct three distinctive plasmonic membranes by polymer-ligand-based strategy in drying-mediated self-assembly at the air/water interfaces. The plasmonic membranes exhibit monolayered morphology with nanoscale assembled ordering but macroscopic lateral dimensions, inducing enhanced near-field confinement and uniform hot-spot distribution. By choosing 4-aminothiophenol and bovine serum albumin (BSA) as a model analyte, we establish an ultrasensitive assay for label-free SERS detection. The detection limit of BSA can reach 15 nM, and the enhancement factor reached 4.3 × 105, enabling a promising avenue for its clinical application in ultrasensitive biodiagnostics.

特别声明

1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。

2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。

3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。

4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。